Moderna Stock Jumps 12% Amid Bird Flu and COVID-19 Concerns

Explore why Moderna stock surged nearly 12%, driven by rising bird flu worries and an uptick in COVID-19 cases. Learn more about this market reaction.

A dynamic stock market chart with a focus on Moderna's stock symbol, highlighted in green, against a
Moderna Stock Jumps 12% Amid Bird Flu and COVID-19 Concerns

Moderna stock surged nearly 12% on rising bird flu concerns and COVID-19 uptick.

Source